Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2026 | 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,523,293 | 1,400,723 | 1,020,951 | 897,556 | 779,437 |
| Depreciation Amortization | 244,152 | 235,811 | 216,209 | 197,562 | 193,841 |
| Accounts receivable | -96,778 | -76,684 | -134,278 | -106,511 | 19,346 |
| Other Working Capital | -74,243 | 16,738 | 44,784 | -462,127 | -708,076 |
| Other Operating Activity | 209,405 | 175,000 | 253,594 | 166,819 | 66,599 |
| Operating Cash Flow | $1,805,829 | $1,751,588 | $1,401,260 | $693,299 | $351,147 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,784 | -1,788 | -11,765 | -28,292 | -13,922 |
| PPE Investments | -156,285 | -89,865 | -99,460 | -119,672 | -134,835 |
| Net Acquisitions | -350,724 | -139,248 | -133,464 | -1,012,749 | -42,784 |
| Purchase Sale Intangibles | -20,888 | -10,777 | -15,396 | -14,328 | -21,201 |
| Other Investing Activity | -12,406 | 30,856 | -25,095 | 868 | -38,377 |
| Investing Cash Flow | $-545,199 | $-200,045 | $-269,784 | $-1,159,845 | $-229,918 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 105,000 | 1,070,000 | 288,000 |
| Debt Repayment | -10,000 | -40,000 | -835,000 | -405,000 | -166,000 |
| Common Stock Issued | 74,503 | 74,439 | 53,094 | 49,142 | 47,384 |
| Common Stock Repurchased | -700,037 | -300,025 | -150,011 | 0 | N/A |
| Dividend Paid | -349,662 | -310,880 | -282,320 | -258,276 | -245,341 |
| Other Financing Activity | -21,833 | -29,787 | -10,050 | -32,992 | -52,406 |
| Financing Cash Flow | $-1,007,029 | $-606,253 | $-1,119,287 | $422,874 | $-128,363 |
| Exchange Rate Effect | 6,183 | 25,799 | -1,719 | -2,147 | -14,434 |
| Beginning Cash Position | 1,209,450 | 238,361 | 227,891 | 273,710 | 295,278 |
| End Cash Position | 1,469,234 | 1,209,450 | 238,361 | 227,891 | 273,710 |
| Net Cash Flow | $259,784 | $971,089 | $10,470 | $-45,819 | $-21,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,805,829 | 1,751,588 | 1,401,260 | 693,299 | 351,147 |
| Capital Expenditure | -156,285 | -89,865 | -99,460 | -119,672 | -134,835 |
| Free Cash Flow | 1,649,544 | 1,661,723 | 1,301,800 | 573,627 | 216,312 |